532167 OMKARPH

Omkar Pharmachem Share Price

₹28.28 0.00 (0.00%)

23 Nov, 2024 21:48

SIP TrendupStart SIP in OMKARPH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 1.8%
  • Over 3 Month + 1.8%
  • Over 6 Month + 28.84%
  • Over 1 Year + 35.96%
SIP Lightning

Smart Investing Starts Here Start SIP with Omkar Pharmachem for Steady Growth!

Invest Now

Omkar Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Omkar Pharmachem Financials

Omkar Pharmachem Technicals

EMA & SMA

Current Price
₹28.28
0 (0%)
pointer
  • stock-down_img
  • Bullish Moving Average 14
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹25.72
  • 50 Day
  • ₹23.91
  • 100 Day
  • ₹21.74
  • 200 Day
  • -

Resistance and Support

28.28 Pivot Speed
  • R3 28.28
  • R2 28.28
  • R1 28.28
  • S1 28.28
  • S2 28.28
  • S3 28.28

What's your outlook on Omkar Pharmachem?

You can only vote for once

Omkar Pharmachem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-12 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results

Omkar Pharmachem F&O

Omkar Pharmachem Shareholding Pattern

No data available.

About Omkar Pharmachem

  • NSE Symbol
  • OMKARPH
  • BSE Symbol
  • 532167
  • ISIN
  • INE501C01015

Similar Stocks to Omkar Pharmachem

Omkar Pharmachem FAQs

Omkar Pharmachem share price is ₹28 As on 23 November, 2024 | 21:34

The Market Cap of Omkar Pharmachem is ₹28.5 Cr As on 23 November, 2024 | 21:34

The P/E ratio of Omkar Pharmachem is 151.8 As on 23 November, 2024 | 21:34

The PB ratio of Omkar Pharmachem is 3.1 As on 23 November, 2024 | 21:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23